The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline
Open accessAbstract
Patients with cancer frequently experience symptoms related to their disease or treatment-related toxicities. Symptom management through optimal supportive care is a foundation of quality care. While objective toxicities and laboratory results are amenable to reporting by health care personnel, subjective experiences such as symptoms are best reported by patients themselves.1 Traditionally, patients are relied upon to discuss symptoms and side-effects with the clinical team during hospital and clinic visits, when contacting their health care team between visits via telephone or, more recently, electronic messaging.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This value has been recognized by the European Society of Medical Oncology (ESMO), which published a clinical guideline in 2022 supporting the implementation of RPM based on ePROs in routine clinical care during systemic cancer treatment, specifically including digital systems connecting patients and health care teams with proactive alerts for severe and worsening symptoms.16”
From Implementation of a remote symptom monitoring pathway in oncology care: analysis of real-world experience across 33 cancer centres in France and Belgium (2024) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, & U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health (2006) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-4-79 · Cited by 2,856
Basch, E., Deal, A. M., Kris, M. G., Scher, H. I., Hudis, C. A., Sabbatini, P., Rogak, L., Bennett, A. V., Dueck, A. C., Atkinson, T. M., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.0830 · Cited by 2,593
Self-citationBasch, E., Deal, A. M., Dueck, A. C., Scher, H. I., Kris, M. G., Hudis, C., & Schrag, D. (2017) · JAMA · doi:10.1001/jama.2017.7156 · Cited by 2,302
Self-citationBakitas, M., Lyons, K. D., Hegel, M. T., Balan, S., Brokaw, F. C., Seville, J., Hull, J. G., Li, Z., Tosteson, T. D., Byock, I. R., et al. (2009) · JAMA · doi:10.1001/jama.2009.1198 · Cited by 1,726
Kotronoulas, G., Kearney, N., Maguire, R., Harrow, A., Domenico, D. D., Croy, S., & MacGillivray, S. A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.5948 · Cited by 953
Reeve, B. B., Wyrwich, K. W., Wu, A. W., Velikova, G., Terwee, C. B., Snyder, C. F., Schwartz, C. E., Revicki, D. A., Moinpour, C. M., McLeod, L., et al. (2013) · Quality of Life Research · doi:10.1007/s11136-012-0344-y · Cited by 887
Snyder, C., Aaronson, N., Choucair, A., Elliott, T. E., Greenhalgh, J., Halyard, M., Hess, R., Miller, D. M., Reeve, B., & Santana, M. (2012) · Quality of Life Research · doi:10.1007/s11136-011-0054-x · Cited by 808
Basch, E., Iasonos, A., McDonough, T., Barz, A., Culkin, A., Kris, M. G., Scher, H. I., & Schrag, D. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70910-x · Cited by 653
Self-citationThe Missing Voice of Patients in Drug-Safety Reporting
Basch, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmp0911494 · Cited by 646
Self-citationDykewicz, C. A. (2001) · Clinical Infectious Diseases · doi:10.1086/321805 · Cited by 637
Research works printed but not linked: 3
- Coombes, 2003, Under-reporting of symptoms in patients with early breast cancer who have received tamoxifen treatment for 2–3 years, Proc Am Soc Clin Oncol, 22, 48
- Stover, 2019, Demographic and symptom differences in PRO-TECT trial (AFT-39) cancer patients electing to complete weekly home patient-reported outcome measures (PROMs) via an automated phone call vs. email: implications for implementing PROs into routine care, Qual Life Res, 28, S1
- Breen, 2012, Improving the management of chemotherapy toxicities in haematological cancer patients: a phase II randomised controlled trial of the Patient Remote Intervention and Symptom Management System (PRISMS), Asia Pac J Clin Oncol, 8, 312
Cited by
Sorted by citations
Items 501–510 of 510
Treloar, A., Grimison, P., Choi, V., Young, J., Mayer, K., Li, T., Boyle, F. M., King, T., Mizrahi, D., Horvath, L. G., et al. (2026) · Supportive Care in Cancer · doi:10.1007/s00520-026-11296-4
Vorbach, S. M., Pilz, M. J., Thumfart, M., Venderbos, L. D. F., Arraras, J. I., Bultijnck, R., Mahilall, R., Jiménez-Jiménez, E., Müller, J. A., Schmidt, H., et al. (2026) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2026.111817
Crafoord, M.-T., Fjell, M., & Gustavell, T. (2026) · Journal of Advanced Nursing · doi:10.1111/jan.70781
When the tumor improves before the patient does: Keeping supportive care open after a good response
Cheng, C.-H., Lin, C.-Y., Yu, S.-H., Liu, Y.-T., & Tu, C. Y. (2026) · Palliative & Supportive Care · doi:10.1017/s1478951526103642
Starling, N., Ajani, J. A., Shitara, K., Gu, J., Mhatre, S. K., Hogea, C. S., Koralek, D. O., Hammond, C., Lambert, A., & Lordick, F. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1863920
Horie, Y., Oyamada, S., Kawakami, H., Fumita, S., Izawa, N., Miyaji, T., Kawaguchi, T., Yamaguchi, T., & Nakajima, T. E. (2026) · International Journal of Clinical Oncology · doi:10.1007/s10147-026-03213-w
Furuya, N., Yanagisawa, T., Tatematsu, N., & Hayashi, K. (2026) · Supportive Care in Cancer · doi:10.1007/s00520-026-11408-0
Schollmeyer, M., Schmidt, H., Müller, J. A., Vordermark, D., & Nordhausen, T. (2026) · Radiation Oncology · doi:10.1186/s13014-026-02947-1
Renaud, L., Gallay, L., & Tran, A. (2026) · Le Pharmacien Clinicien · doi:10.1016/j.phacli.2026.04.008
Deutsch, T. M., Volmer, L. L., Feißt, M., Heise, M., Haßdenteufel, K., Tretschock, L. M., Pfob, A., Breit, C., Александровна, М. Е., Stefanovic, S., et al. (2026) · Journal of Medical Internet Research · doi:10.2196/95155
Metadata
- Authors
- Di Maio, M., Basch, E., Denis, F., Fallowfield, L. J., Ganz, P. A., Howell, D., Kowalski, C., Perrone, F., Stover, A. M., Sundaresan, P., Warrington, L., Zhang, L., Apostolidis, K., Freeman-Daily, J., Ripamonti, C. I., & Santini, D.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Université Paris Cité (FR)
- Brighton and Sussex Medical School (GB)
- University of California, Los Angeles (US)
- Princess Margaret Cancer Centre (CA)
- German Cancer Society (DE)
- Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT)
- The University of Sydney (AU)
- University of Leeds (GB)
- Sun Yat-sen University Cancer Center (CN)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- Università Campus Bio-Medico (IT)
- ORCID
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2022-09
- Volume
- 33
- Issue
- 9
- Pages
- 878-892
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W4224250553
- Cited by
- 509
- References
- 108
- Citations by year
- 2026: 126 · 2025: 129 · 2024: 149 · 2023: 88 · 2022: 17
- FWCI
- 40.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Annals of Oncology (publishedVersion, other-oa)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, other-oa)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- Sussex Research Online (University of Sussex) (submittedVersion, cc-by-nc-nd)
- Figshare (submittedVersion, cc-by-nc-nd)
- Funders
- Breast Cancer Research Foundation
- LUNGevity Foundation
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Leukemia and Lymphoma Society
- International Association for the Study of Lung Cancer
- Patient-Centered Outcomes Research Institute
- American Society of Clinical Oncology
- Associazione Italiana di Oncologia Medica
- Bladder Cancer Advocacy Network
- Exelixis
- Les Laboratories Pierre Fabre
- BeiGene
- Incyte
- Association of Community Cancer Centers
- Veracyte
- UroGen Pharma
- York University
- University of Oxford
- Cancer Australia
- Astellas Pharma
- Angelini Pharma
- European Society for Medical Oncology
- Ipsen
- National Institutes of Health
- Agency for Healthcare Research and Quality
- Genentech
- Chugai Pharmaceutical
- National Cancer Institute
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- patient-reported outcome measures, cancer symptoms, supportive care, symptom management, treatment toxicity, patient-reported symptoms, quality of life
- MeSH terms
- Patient Reported Outcome Measures, Humans, Neoplasms, Surveys and Questionnaires
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
